Fact CheckerSign in

NCT07460583Not yet recruiting

ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes

Source: ClinicalTrials.gov · Last updated 15 Oct 2026

Brief summary (registry, in English)

AI-Guided Coronary CT Angiography Screening in Former High-Intensity Athletes

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
27 Feb 2026
Start date
28 Jan 2027
Primary completion date
31 Jan 2027
Lead sponsor
Baylor Research Institute
NCT number
NCT07460583

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 28 Jan 2027 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known iodinated contrast allergy
  • Uncontrolled arrhythmia

Lab values

  • eGFR \<40 mL/min/1.73 m²
  • Contraindication to beta-blocker, Calcium Channel Blockers and nitroglycerin

Other

  • Weight \>450 lbs. (scanner table limit)
  • Inability to hold breath \>10 seconds
  • Taking part in another research study that has not given their permission to participate in this one
  • Pregnancy

Who the study is looking for

  • Former professional or collegiate high-intensity athletes (e.g., NFL alumni, Division I athletes, or equivalent competitive-level participants).
  • Age ≥30 years

Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Baylor Scott & White The Heart Hospital - Plano
Coordinator of this site? Confirm its status
PlanoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.